350 related articles for article (PubMed ID: 7309892)
1. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of glycosaminoglycans in disseminated neoplasm.
Manley G; Bower L; Anson A
J Clin Pathol; 1978 May; 31(5):447-53. PubMed ID: 649771
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
Kelleher PC
Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
[TBL] [Abstract][Full Text] [Related]
5. An electrophoretic fraction of urinary glycosaminoglycans reflecting connective tissue turnover.
Poulsen JH
Scand J Clin Lab Invest; 1981 Nov; 41(7):675-81. PubMed ID: 7339868
[TBL] [Abstract][Full Text] [Related]
6. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
Hamdy NA; Papapoulos SE; Colwell A; Eastell R; Russell RG
Bone Miner; 1993 Jul; 22(1):1-8. PubMed ID: 8219934
[TBL] [Abstract][Full Text] [Related]
7. Excretion patterns of glycosaminoglycans and glycoproteins in normal human urine.
Manley G; Severn M; Hawksworth J
J Clin Pathol; 1968 May; 21(3):339-45. PubMed ID: 4235293
[TBL] [Abstract][Full Text] [Related]
8. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of glycosaminoglycans in the various forms of gargoylism.
Manley G; Williams U
J Clin Pathol; 1969 Jan; 22(1):67-75. PubMed ID: 4239429
[TBL] [Abstract][Full Text] [Related]
10. Galactosyl hydroxylysine in assessment of Paget's bone disease.
Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Torres R; de la Piedra C; Rapado A
Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
[TBL] [Abstract][Full Text] [Related]
12. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
13. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
14. CPC precipitable uronic acid: creatinine ratio in random urine samples collected from normal children.
Pennock CA; White F; Wharton BA
Acta Paediatr Scand; 1972 Mar; 61(2):125-7. PubMed ID: 4258717
[No Abstract] [Full Text] [Related]
15. A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
Szymanowicz A; Malgras A; Cosson R; Randoux A; Borel JP
Ann Biol Clin (Paris); 1975; 33(5):351-8. PubMed ID: 1217759
[TBL] [Abstract][Full Text] [Related]
16. Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.
Krane SM; Muñoz AJ; Harris ED
Science; 1967 Aug; 157(3789):713-6. PubMed ID: 6028049
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Reginster JY; Colson F; Morlock G; Combe B; Ethgen D; Geusens P
Arthritis Rheum; 1992 Aug; 35(8):967-74. PubMed ID: 1642662
[TBL] [Abstract][Full Text] [Related]
18. Urinary polypeptides related to collagen synthesis.
Krane SM; Muñoz AJ; Harris ED
J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
Papapoulos SE; Frölich M
J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
[TBL] [Abstract][Full Text] [Related]
20. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
Raab W; Czitober H
Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
